News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SIEGALL CLAY B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Immunome Inc.|
Txns:
| Bought 169,204 shares
@ $5.91, valued at
$1000k
|
|
| 10/04/2023 |
3
| SIEGALL CLAY B (President and CEO) has filed a Form 3 on Immunome Inc. |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| SIEGALL CLAY B (President & CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,885 shares
@ $144.3186, valued at
$272k
|
|
| 04/08/2022 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,649 shares
@ $151.42, valued at
$249.7k
Sold 2,100 shares
@ $152.59, valued at
$320.4k
Sold 4,692 shares
@ $153.38, valued at
$719.7k
Sold 2,400 shares
@ $154.36, valued at
$370.5k
Sold 3,828 shares
@ $155.83, valued at
$596.5k
Sold 1,900 shares
@ $156.48, valued at
$297.3k
Sold 474 shares
@ $157.23, valued at
$74.5k
Exercised 1,649 options to buy
@ $26.1, valued at
$43k
Exercised 2,100 options to buy
@ $26.1, valued at
$54.8k
Exercised 4,692 options to buy
@ $26.1, valued at
$122.5k
Exercised 2,400 options to buy
@ $26.1, valued at
$62.6k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| SIEGALL CLAY B (President & CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 100 shares
@ $137.29, valued at
$13.7k
Sold 3,574 shares
@ $138.97, valued at
$496.7k
Sold 8,985 shares
@ $139.96, valued at
$1.3M
Sold 4,084 shares
@ $140.83, valued at
$575.1k
Sold 300 shares
@ $141.56, valued at
$42.5k
Exercised 100 options to buy
@ $26.1, valued at
$2.6k
Exercised 3,574 options to buy
@ $26.1, valued at
$93.3k
Exercised 8,985 options to buy
@ $26.1, valued at
$234.5k
Exercised 4,084 options to buy
@ $26.1, valued at
$106.6k
Exercised 300 options to buy
@ $26.1, valued at
$7.8k
|
|
| 01/11/2022 |
4
| SIEGALL CLAY B (President & CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,100 shares
@ $147.16, valued at
$161.9k
Sold 3,221 shares
@ $145.84, valued at
$469.8k
Sold 4,560 shares
@ $144.82, valued at
$660.4k
Sold 8,163 shares
@ $143.91, valued at
$1.2M
Exercised 1,100 options to buy
@ $26.1, valued at
$28.7k
Exercised 3,221 options to buy
@ $26.1, valued at
$84.1k
Exercised 4,560 options to buy
@ $26.1, valued at
$119k
Exercised 8,163 options to buy
@ $26.1, valued at
$213.1k
|
|
| 12/22/2021 |
4
| SIEGALL CLAY B (President & CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,227 shares
@ $149.85, valued at
$183.9k
|
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 3,432 shares
@ $158.64, valued at
$544.5k
Sold 6,165 shares
@ $157.92, valued at
$973.6k
Sold 4,488 shares
@ $156.94, valued at
$704.3k
Sold 310 shares
@ $158.29, valued at
$49.1k
Sold 2,355 shares
@ $157.31, valued at
$370.5k
Sold 7,412 shares
@ $156.43, valued at
$1.2M
Sold 5,191 shares
@ $155.7, valued at
$808.2k
Exercised 3,432 options to buy
@ $15.46, valued at
$53.1k
Exercised 6,165 options to buy
@ $15.46, valued at
$95.3k
Exercised 4,488 options to buy
@ $15.46, valued at
$69.4k
Exercised 310 options to buy
@ $15.46, valued at
$4.8k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 6,824 shares
@ $180, valued at
$1.2M
Sold 14,908 shares
@ $179.17, valued at
$2.7M
Sold 1,080 shares
@ $178.36, valued at
$192.6k
Sold 1,741 shares
@ $179.4, valued at
$312.3k
Sold 3,590 shares
@ $180.25, valued at
$647.1k
Sold 3,352 shares
@ $181.38, valued at
$608k
Sold 5,056 shares
@ $182.49, valued at
$922.7k
Sold 904 shares
@ $182.97, valued at
$165.4k
Exercised 6,824 options to buy
@ $15.46, valued at
$105.5k
Exercised 14,908 options to buy
@ $15.46, valued at
$230.5k
Exercised 1,080 options to buy
@ $15.46, valued at
$16.7k
|
|
| 12/04/2020 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 100 shares
@ $180.91, valued at
$18.1k
Sold 10,936 shares
@ $180.14, valued at
$2M
Sold 4,844 shares
@ $179.14, valued at
$867.8k
Sold 3,253 shares
@ $178.16, valued at
$579.6k
Sold 1,120 shares
@ $177.28, valued at
$198.6k
Sold 1,000 shares
@ $176.18, valued at
$176.2k
Exercised 100 options to buy
@ $15.46, valued at
$1.5k
Exercised 10,936 options to buy
@ $15.46, valued at
$169.1k
Exercised 4,844 options to buy
@ $15.46, valued at
$74.9k
Exercised 3,253 options to buy
@ $15.46, valued at
$50.3k
Exercised 1,120 options to buy
@ $15.46, valued at
$17.3k
|
|
| 09/02/2020 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 9,564 shares
@ $155.6942, valued at
$1.5M
Sold 4,787 shares
@ $155.6942, valued at
$745.3k
|
|
| 08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| SIEGALL CLAY B (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 23,404 shares
@ $85.55, valued at
$2M
Sold 9,750 shares
@ $85.01, valued at
$828.8k
Sold 1,596 shares
@ $85.01, valued at
$135.7k
Exercised 5,904 options to buy
@ $40.37, valued at
$238.3k
Exercised 17,500 options to buy
@ $21, valued at
$367.5k
Exercised 1,596 options to buy
@ $40.37, valued at
$64.4k
|
|
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|